Our areas
of focus
Discovering breakthrough therapies begins with understanding the diseases themselves. Learn more about Pfizer’s commitment to tackling some of the most challenging cancers.
Breast

Breast cancer
Worldwide, breast cancer is the second-most common cancer in women, besides certain skin cancers. In fact, it’s estimated that breast cancer will be diagnosed in 12% of all US women over their lifetimes. The risk of death from breast cancer is going down—thanks to earlier detection, greater awareness, and advances in treatments. Pfizer is a leader in the fight against breast cancer with approved medicines. And we’re testing more potential targeted treatments in our clinical trials every day.
Genitourinary
Hematological

Blood cancer
Annually, nearly 100,000 people in the US are diagnosed with blood cancers like multiple myeloma, leukemia, and lymphoma. Pfizer is at the forefront of innovative blood cancer care with approved medicines and more candidates in testing. Follow our progress in the fight against blood cancer.